CE & Events
- This event has passed.
APhA Pharmacy-Based Cardiovascular Disease Risk Management
Hosted by: Virginia Pharmacists Association
August 18, 2019
Sheraton Virginia Beach
For questions about this program, please contact: VPhA at email@example.com
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
- Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
- Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
- Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
- Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
- Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management certificate training program has two components: web-based interactive self-study with assessment and the live seminar with online final assessment. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.
Key Learning Objectives of the Live Training Seminar
- Assess a patient’s risk for atherosclerotic cardiovascular disease.
- Describe how to use patient factors that are not included in risk calculators to guide treatment selections.
- Explain how to apply national treatment guidelines for hypertension and dyslipidemia to individual patients.
- Discuss how to identify patients who are appropriate for the use of aspirin for primary prevention.
- Describe how treatment approaches for dyslipidemia and hypertension should be modified for special populations, including those with diabetes, renal insufficiency, and elevated hepatic transaminase levels.
- Recommend appropriate lifestyle interventions that reduce cardiovascular risk.
- Apply patient education and counseling strategies, including motivational interviewing, to support lifestyle modifications.
- Demonstrate how to measure blood pressure.
- Discuss the use of point-of-care lipid testing in cardiovascular risk management.
- Discuss how to implement cardiovascular risk management services in various practice settings, including potential billing options and quality measures.
For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website, https://www.pharmacist.com/pharmacy-based-cardiovascular-disease-risk-management
- Welcome, Introductions and Acknowledgements
- Cardiovascular Disease Risk Assessment and Treatment Decisions
- Special Situations and Clinical Updates
- Clinical Updates
- Lifestyle Modifications and Motivational Interviewing
- Lunch and Networking
- Motivational Interviewing Activity
- Patient Assessment Skills
- Blood Pressure Measurement Practice
- Business and Practice Models
- Transitions of Care Patient Case
- Take Home Points and Final Instructions
Evan Sisson, Pharm.D., MSHA, BCACP, CDE, FAADE
Virginia Commonwealth University School of Pharmacy
Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements
Release Date: 09/01/2018;
Expiration Date: 09/01/2021 PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the seminar attended or by the expiration date, whichever is sooner.
Activity Type: Practice-based
Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
Target Audience: Pharmacists in all practice settings
- Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs). ACPE Universal Activity Number: 0202-9999-18-247-H01-P
- Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU). ACPE Universal Activity Number: 0202-9999-18-248-L01-P
Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at https://nabp.pharmacy/cpe-monitor-service/. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management was developed by the American Pharmacists Association.
The fee to cancel is $150. VPhA must receive your cancellation notice in writing at least two weeks prior to the live program offering. After that, there will be no refunds granted. Registration fees cannot be re-allocated to future offerings of this certification program due to the multiple steps involved with processing CE credits.